5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.97▲ | 1.98▲ | 2.00▼ | 2.02▼ | 1.83▲ |
MA10 | 1.99▼ | 2.03▼ | 2.05▼ | 1.92▲ | 1.87▲ |
MA20 | 2.04▼ | 2.05▼ | 2.04▼ | 1.86▲ | 1.76▲ |
MA50 | 2.03▼ | 1.98▼ | 1.95▲ | 1.88▲ | 1.58▲ |
MA100 | 1.93▲ | 1.87▲ | 1.87▲ | 1.77▲ | 1.85▲ |
MA200 | 1.88▲ | 1.93▲ | 1.89▲ | 1.63▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.013▼ | -0.018▼ | -0.020▼ | 0.025▲ | N/A |
RSI | 42.644▼ | 44.887▼ | 45.846▼ | 51.209▲ | N/A |
STOCH | 6.250▼ | 8.120▼ | 22.454 | 76.325 | 31.706 |
WILL %R | -87.500▼ | -87.500▼ | -87.500▼ | -41.818 | -57.895 |
CCI | -50.439 | -98.627 | -111.263▼ | 61.907 | 83.451 |
▼ MA | $ADIL MA(20) Crossed Below MA(50) | Set Alert |
Tuesday, January 12, 2021 01:41 AM
About Adial Pharmaceuticals, Inc. Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new ...
|
Monday, January 11, 2021 06:24 PM
(MENAFN - ACCESSWIRE) CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2021 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ( & quot;Adial & quot; or the & quot ...
|
Monday, January 11, 2021 02:10 PM
CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2021 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/01/21 | 2.07 | 2.10 | 1.92 | 1.92 | 329,255 |
14/01/21 | 2.09 | 2.14 | 2.03 | 2.06 | 324,840 |
13/01/21 | 2.03 | 2.15 | 1.99 | 2.08 | 717,400 |
12/01/21 | 2.04 | 2.05 | 1.90 | 1.99 | 435,000 |
11/01/21 | 1.93 | 2.13 | 1.88 | 2.07 | 2,107,767 |
08/01/21 | 1.85 | 1.97 | 1.8479 | 1.93 | 682,100 |
07/01/21 | 1.79 | 1.85 | 1.7801 | 1.84 | 144,981 |
06/01/21 | 1.82 | 1.85 | 1.74 | 1.76 | 177,322 |
05/01/21 | 1.73 | 1.83 | 1.73 | 1.82 | 296,787 |
04/01/21 | 1.69 | 1.76 | 1.68 | 1.73 | 177,243 |
|
|
||||
|
|
||||
|
|